المؤلفون: Lennep, J.E.R. van, Tokgözoglu, L.S., Badimon, L., Dumanski, S.M., Gulati, M., Hess, C.N., Holven, K.B., Kavousi, M., Kayikçioglu, M., Lutgens, E., Michos, E.D., Prescott, E., Stock, J.K., Tybjaerg-Hansen, A., Wermer, M.J.H., Benn, M.

المصدر: European Heart Journal

مصطلحات موضوعية: Women, Atherosclerotic cardiovascular disease, Sex-specific risk, Lipids, Cholesterol, Triglycerides, Lipoprotein(a)

وصف الملف: application/pdf

العلاقة: https://academic.oup.com/eurheartj/article/44/39/4157/7249105Test; lumc-id: 185191769; https://hdl.handle.net/1887/3714029Test

الإتاحة: https://doi.org/10.1093/eurheartj/ehad472Test
https://hdl.handle.net/1887/3714029Test
https://academic.oup.com/eurheartj/article/44/39/4157/7249105Test

المؤلفون: Ference B.A., Ginsberg H.N., Graham I., Ray K.K., Packard C.J., Bruckert E., Hegele R.A., Krauss R.M., Raal F.J., Schunkert H., Watt G.F., Borén J., Fazio S., Horton J.D., Masana L., Nicholls S.J., Nordestgaard B.G., Van De Sluis B., Taskinen M.R., Tokgözo?lu L., Landmesser U., Laufs U., Wiklund O., Stock J.K., Chapman M.J., Catapano A.L.

المساهمون: Universitat Rovira i Virgili

المصدر: European Heart Journal ; 10.1093/eurheartj/ehx144 ; European Heart Journal. 38 (32): 2459-2472

مصطلحات موضوعية: Cardiac & Cardiovascular Systems,Cardiology and Cardiovascular Medicine, Statin therapy, Statin, Risk, Retention, Recommendations, Pcsk9, Mendelian randomization, Low-density lipoprotein, Ldl cholesterol, General-population, Familial hypercholesterolemia, Ezetimibe, Coronary-heart-disease, Clinical trials, Causality, Cardiovascular disease, Atherosclerosis, Association, Saúde coletiva, Nutrição, Medicina iii, Medicina ii, Medicina i, Interdisciplinar, General medicine, Farmacia, Educação física, Direito, Ciências biológicas ii

العلاقة: http://hdl.handle.net/20.500.11797/imarina5251672Test

الإتاحة: https://doi.org/20.500.11797/imarina5251672Test
https://doi.org/10.1093/eurheartj/ehx144Test
https://hdl.handle.net/20.500.11797/imarina5251672Test

المؤلفون: Fruchart, J.C., Santos, R.D., Aguilar-Salinas, C., Aikawa, M., Al Rasadi, K., Amarenco, P., Barter, P.J., Ceska, R., Corsini, A., Després, J.P., Duriez, P., Eckel, R.H., Ezhov, M.V., Farnier, M., Ginsberg, H.N., Hermans, M.P., Ishibashi, S., Karpe, F., Kodama, T., Koenig, W., Krempf, M., Lim, S., Lorenzatti, A.J., McPherson, R., Nuñez-Cortes, J.M., Nordestgaard, B.G., Ogawa, H., Packard, C.J., Plutzky, J., Ponte-Negretti, C.I., Pradhan, A., Ray, K.K., Reiner, Ž., Ridker, P.M., Ruscica, M., Sadikot, S., Shimano, H., Sritara, P., Stock, J.K., Su, T.C., Susekov, A.V., Tartar, A., Taskinen, M.R., Tenenbaum, A., Tokgözoğlu, L.S., Tomlinson, B., Tybjærg-Hansen, A., Valensi, P., Vrablík, M., Wahli, W., Watts, G.F., Yamashita, S., Yokote, K., Zambon, A., Libby, P.

المصدر: Cardiovascular diabetology, vol. 18, no. 1, pp. 71

مصطلحات موضوعية: Animals, Benzoxazoles/adverse effects, Benzoxazoles/therapeutic use, Biomarkers/blood, Butyrates/adverse effects, Butyrates/therapeutic use, Cardiovascular Diseases/blood, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/prevention & control, Consensus, Dyslipidemias/blood, Dyslipidemias/diagnosis, Dyslipidemias/drug therapy, Humans, Hypolipidemic Agents/adverse effects, Hypolipidemic Agents/therapeutic use, Lipids/blood, Molecular Targeted Therapy, PPAR alpha/agonists, PPAR alpha/metabolism, Patient Safety, Risk Assessment, Risk Factors, Signal Transduction, Treatment Outcome, Atherogenic dyslipidemia, Diabetes, Inflammation, PROMINENT, Pemafibrate (K-877), Remnant cholesterol, Residual cardiovascular risk, SPPARMalpha, Selective peroxisome proliferator-activated receptor alpha modulator, Triglycerides, Visceral obesity

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______1900::1e42e4b07a96300e14b1450540aec81bTest
https://serval.unil.ch/resource/serval:BIB_A62033B5071E.P001/REF.pdfTest

المؤلفون: Brookes, E., de Santiago, I., Hebenstreit, D., Morris, K.J., Carroll, T., Xie, S.Q., Stock, J.K., Heidemann, M., Eick, D., Nozaki, N., Kimura, H., Ragoussis, J., Teichmann, S.A., Pombo, A.

مصطلحات موضوعية: Cardiovascular and Metabolic Diseases

العلاقة: Polycomb associates genome-wide with a specific RNA polymerase II variant, and regulates metabolic genes in ESCs. Brookes, E. and de Santiago, I. and Hebenstreit, D. and Morris, K.J. and Carroll, T. and Xie, S.Q. and Stock, J.K. and Heidemann, M. and Eick, D. and Nozaki, N. and Kimura, H. and Ragoussis, J. and Teichmann, S.A. and Pombo, A. Cell Stem Cell 10 (2): 157-170. 3 February 2012

الإتاحة: https://doi.org/10.1016/j.stem.2011.12.017Test
http://edoc.mdc-berlin.de/13254Test/
https://edoc.mdc-berlin.de/13254Test/

المؤلفون: Stock, J.K., Giadrossi, S., Casanova, M., Brookes, E., Vidal, M., Koseki, H., Brockdorff, N., Fisher, A.G., Pombo, A.

مصطلحات موضوعية: Cardiovascular and Metabolic Diseases

العلاقة: Ring1-mediated ubiquitination of H2A restrains poised RNA polymerase II at bivalent genes in mouse ES cells. Stock, J.K. and Giadrossi, S. and Casanova, M. and Brookes, E. and Vidal, M. and Koseki, H. and Brockdorff, N. and Fisher, A.G. and Pombo, A. Nature Cell Biology 9 (12): 1428-1435. December 2007

الإتاحة: https://doi.org/10.1038/ncb1663Test
http://edoc.mdc-berlin.de/13306Test/
https://edoc.mdc-berlin.de/13306Test/

المؤلفون: Alberto Mello e Silva, Maciej Banach, Maurizio Averna, Eric Bruckert, Michel Farnier, Alberico L. Catapano, Winfried März, Paolo Magni, Alberto Zambon, Dan Gaita, José Luis Zamorano, Luis Masana, Zeljko Reiner, Heinz Drexel, Lale Tokgozoglu, Michal Vrablík, Jane K Stock, Emilio Ros

المساهمون: Averna M., Banach M., Bruckert E., Drexel H., Farnier M., Gaita D., Magni P., Marz W., Masana L., Mello e Silva A., Reiner Z., Ros E., Vrablik M., Zambon A., Zamorano J.L., Stock J.K., Tokgozoglu L.S., Catapano A.L., School of Medicine, University of Patras [Greece], Medical University of Łódź (MUL), Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Institute of cardiometabolism and nutrition (ICAN), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), CHU Dijon, Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Dipartimento di Ingegneria Industriale e dell’Informazione [Pavia, Italia], Università degli Studi di Pavia, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Karl-Franzens-Universität Graz, Universitat Rovira i Virgili

المصدر: Atherosclerosis
Atherosclerosis, Elsevier, 2021, 325, pp.99-109. ⟨10.1016/j.atherosclerosis.2021.03.039⟩

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Statin, Settore MED/09 - Medicina Interna, Combination therapy, medicine.drug_class, High-risk, 2019 ESC/EAS Dyslipidaemia Guideline, Lipid goal, 030204 cardiovascular system & hematology, Triglyceride, 03 medical and health sciences, 0302 clinical medicine, Combined treatment, cardiovascular disease, Internal medicine, medicine, Humans, triglycerides, 2019 ESC/EAS Dyslipidaemia Guidelines, combination treatment, LDL cholesterol, lipid goals, high-risk, business.industry, Task force, Anticholesteremic Agents, PCSK9, Cholesterol, LDL, [SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism, Atherosclerosis, 3. Good health, 030104 developmental biology, Diabetes Mellitus, Type 2, Combination treatment, Atherosclerosi, European atherosclerosis society, Kexin, lipids (amino acids, peptides, and proteins), Proprotein Convertase 9, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cardiology and Cardiovascular Medicine, business, Very high risk

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71a4c945f64aa4cb72074405e7017abcTest
http://hdl.handle.net/10447/540829Test

المؤلفون: Averna M., Banach M., Bruckert E., Drexel H., Farnier M., Gaita D., Magni P., Marz W., Masana L., Mello e Silva A., Reiner Z., Ros E., Vrablik M., Zambon A., Zamorano J. L., Stock J. K., Tokgozoglu L. S., Catapano A. L.

المساهمون: Averna M., Banach M., Bruckert E., Drexel H., Farnier M., Gaita D., Magni P., Marz W., Masana L., Mello e Silva A., Reiner Z., Ros E., Vrablik M., Zambon A., Zamorano J.L., Stock J.K., Tokgozoglu L.S., Catapano A.L.

مصطلحات موضوعية: 2019 ESC/EAS Dyslipidaemia Guideline, Combination treatment, High-risk, LDL cholesterol, Lipid goal, Triglyceride, Cholesterol, LDL, Proprotein Convertase 9, Atherosclerosi, Diabetes Mellitus, Type 2, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Settore MED/09 - Medicina Interna

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33892925; info:eu-repo/semantics/altIdentifier/wos/WOS:000651615900014; volume:325; firstpage:99; lastpage:109; numberofpages:11; journal:ATHEROSCLEROSIS; http://hdl.handle.net/10447/540829Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85104682235

الإتاحة: https://doi.org/10.1016/j.atherosclerosis.2021.03.039Test
http://hdl.handle.net/10447/540829Test

المؤلفون: Fruchart, J.C., Santos, R.D., Yamashita, S., Libby, P.

المساهمون: International Atherosclerosis Society/R3i Foundation Consensus Panel, Fruchart, J.C., Santos, R.D., Yamashita, S., Aikawa, M., Libby, P., Plutzky, J., Pradhan, A., Ridker, P., Aguilar-Salinas, C., Al Rasadi, K., Amarenco, P., Barter, P.J., Ceska, R., Corsini, A., Ruscica, M., Després, J.P., Duriez, P., Eckel, R.H., Ezhov, M.V., Farnier, M., Ginsberg, H.N., Hermans, M.P., Ishibashi, S., Karpe, F., Kodama, T., Koenig, W., Krempf, M., Lim, S., Lorenzatti, A.J., McPherson, R., Nuñez-Cortes, J.M., Nordestgaard, B.G., Ogawa, H., Packard, C.J., Ponte-Negretti, C.I., Reiner, Ž., Sadikot, S., Shimano, H., Sritara, P., Stock, J.K., Su, T.C., Susekov, A.V., Tartar, A., Taskinen, M.R., Tenenbaum, A., Tokgözoğlu, L.S., Tomlinson, B., Tybjærg-Hansen, A., Valensi, P., Vrablík, M., Wahli, W., Watts, G.F., Yokote, K., Zambon, A.

المصدر: Diabetes & metabolic syndrome, vol. 13, no. 4, pp. 2723-2725

مصطلحات موضوعية: Diabetes Mellitus, Type 2/complications, Diabetic Angiopathies/drug therapy, Diabetic Angiopathies/etiology, Diabetic Angiopathies/metabolism, Humans, PPAR alpha/agonists, PPAR alpha/antagonists & inhibitors, Prognosis

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31405699; info:eu-repo/semantics/altIdentifier/eissn/1878-0334; https://serval.unil.ch/notice/serval:BIB_D94E3A861A64Test; urn:issn:1871-4021

الإتاحة: https://doi.org/10.1016/j.dsx.2019.05.034Test
https://serval.unil.ch/notice/serval:BIB_D94E3A861A64Test